Indian Journal of Medical and Paediatric Oncology

LinksSchließen

Referenz

Ogungbenro K, Patel A, Duncombe R, Nuttall R, Clark J, Lorigan P.
Dose rationalization of pembrolizumab and nivolumab using pharmacokinetic modeling and simulation and cost analysis.

Clin Pharmacol Ther 2018;
103 (04) 582-590

Bibliographische Angaben herunterladen

Aufrufen in: